Bio-Techne (TECH) Long-Term Investments (2010 - 2026)

Bio-Techne has reported Long-Term Investments for 15 years, with the latest figure at $230.8 million in Q2 2026.

• On a quarterly basis, Long-Term Investments fell 2.18% year-over-year to $230.8 million in Q2 2026; TTM through Jun 2026 was $230.8 million, a 2.18% decrease from a year earlier, with the FY2026 full-year figure at $230.8 million, down 2.18% from the prior year.
• Long-Term Investments was $230.8 million for Q2 2026 at Bio-Techne, roughly flat from $231.0 million in the prior quarter.
• The five-year high for Long-Term Investments was $257.0 million in Q1 2023, with the low at $25.0 million in Q2 2022.
• Average Long-Term Investments over 5 years is $204.1 million, with a median of $239.5 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Long-Term Investments surged 923.43% in 2023, then dropped 5.28% in 2024.
• Over 5 years, Long-Term Investments stood at $25.0 million in 2022, then surged by 898.92% to $249.7 million in 2023, then dropped by 3.35% to $241.4 million in 2024, then retreated by 2.62% to $235.0 million in 2025, then decreased by 1.79% to $230.8 million in 2026.
• The last three Long-Term Investments figures came in at $230.8 million (Q2 2026), $231.0 million (Q1 2026), and $235.0 million (Q4 2025), per Business Quant data.